Skip to content

Effect of systemic granulocyte-colony stimulating factor versus placebo on implantation in infertile women

Effect of systemic granulocyte-colony stimulating factor versus placebo on implantation in infertile women: a single blind randomized clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201511269014N85
Enrollment
36
Registered
2015-12-05
Start date
2015-04-04
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility. Female infertility

Interventions

Intervention 1: Injection of granulocyte-colony stimulating factor 300 IU intramuscularly in deltoid muscle at first day and 48 hours later. Intervention 2: Injection of normal saline intramuscularly
Treatment - Drugs
Placebo
Injection of granulocyte-colony stimulating factor 300 IU intramuscularly in deltoid muscle at first day and 48 hours later
Injection of normal saline intramuscularly in deltoid muscle at first day and 48 hours later

Sponsors

Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: (a) being infertile; (b) age of 20 to 40 years. Exclusion criteria: (a) contraindication of pregnancy; (b) secondary infertility due to background disease; (c) infertility because of her spouse; (d) weak response to gonadotropin.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Assessing the formation of gestational sac. Timepoint: 3 weeks after intervention. Method of measurement: By transvaginal ultrasound.

Secondary

MeasureTime frame
Assessing beta human chorionic gonadotropin. Timepoint: 10 days after intervention. Method of measurement: By laboratory test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Nages Mehrabi

Fatemieh Hospital

narges.mehrabi95@gmail.com+98 81 3828 3939

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026